Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorZümrütbaş, Ali E.
dc.contributor.authorÇitgez, Sinharib
dc.contributor.authorAcar, Ömer
dc.contributor.authorİzol, Volkan
dc.contributor.authorUzun, Hakki
dc.contributor.authorKabay, Şahin
dc.contributor.authorDemirkesen, Oktay
dc.contributor.authorYazıcı, Cenk
dc.date.accessioned2022-05-11T14:37:00Z
dc.date.available2022-05-11T14:37:00Z
dc.date.issued2019
dc.identifier.issn0733-2467
dc.identifier.issn1520-6777
dc.identifier.urihttps://doi.org/10.1002/nau.24079
dc.identifier.urihttps://hdl.handle.net/20.500.11776/8522
dc.description.abstractIntroduction Turkish Continence Society aimed to analyze how overactive bladder (OAB) is being managed in routine practice by the urologists in Turkey. Material and methods Fourteen urology departments were randomly selected to represent the whole population in this multicenter study. An online data entry and storage software was created for patient recruitment and data assessment. A survey including demographic data, daily habits, lower urinary tract symptoms, and Turkish-validated OAB-V8 and ICIQ-SF questionnaires were completed by all patients. Second part of the survey, including the questions about clinical evaluation and management of the patient, was completed by the treating physician. Results A total of 507 patients (394 female and 113 male) were included. Behavioral therapy was recommended to 73.2% of female and 81.4% of male patients although bladder diary was requested for 59.5% and 52.7% of the female and male patients, respectively. In the first visit, 86.1% of the female and 89.3% of the male patients were given antimuscarinics (P = .431). Antimuscarinic-related side effects occurred in 94.9% and 88.9% of the female and male patients, respectively (P = .937). However, the rate of medical treatment change due to antimuscarinic-related side effects was only 1.7% in female and 4.8% in male patients at the end of 4 months. Conclusions Behavioral therapy and antimuscarinics were the preferred initial treatment modalities of OAB in concordance with the guidelines. Despite guideline recommendations, bladder diaries were not utilized in half of the patients. Insufficient efficacy appeared to be the main reason for treatment modification.en_US
dc.language.isoengen_US
dc.publisherWileyen_US
dc.identifier.doi10.1002/nau.24079
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectmanagementen_US
dc.subjectmulticenteren_US
dc.subjectoveractive bladderen_US
dc.subjectstudyen_US
dc.subjectUrinary-Tract Symptomsen_US
dc.subjectAntimuscarinic Therapyen_US
dc.subjectBehavioral-Therapyen_US
dc.subjectIncontinenceen_US
dc.subjectTerminologyen_US
dc.subjectDrugen_US
dc.titleThe real-life management of overactive bladder: Turkish Continence Society multicenter prospective cohort study with short-term outcomeen_US
dc.typearticleen_US
dc.relation.ispartofNeurourology and Urodynamicsen_US
dc.departmentFakülteler, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Üroloji Ana Bilim Dalıen_US
dc.authorid0000-0001-6140-5181
dc.authorid0000-0002-3897-2951
dc.authorid0000-0001-5933-402X
dc.authorid0000-0003-2693-9916
dc.authorid0000-0002-6094-9264
dc.identifier.volume38en_US
dc.identifier.issue8en_US
dc.identifier.startpage2170en_US
dc.identifier.endpage2177en_US
dc.institutionauthorYazıcı, Cenk
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.authorscopusid8577975400
dc.authorscopusid18433409900
dc.authorscopusid8615400100
dc.authorscopusid9278394100
dc.authorscopusid7004285752
dc.authorscopusid23050616300
dc.authorscopusid55753628300
dc.authorwosidYazici, Cenk Murat/AAA-4330-2020
dc.authorwosidCitgez, S/AAB-6720-2021
dc.identifier.wosWOS:000479353100001en_US
dc.identifier.scopus2-s2.0-85073584490en_US
dc.identifier.pmid31338880en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster